Results 301 to 310 of about 307,259 (361)
Some of the next articles are maybe not open access.
Allogeneic islet transplantation
Expert Opinion on Biological Therapy, 2007Significant progress has been made in the field of beta-cell replacement therapies by islet transplantation in patients with unstable Type 1 diabetes mellitus (T1DM). Recent clinical trials have shown that islet transplantation can reproducibly lead to insulin independence when adequate islet numbers are implanted.
Simona, Marzorati +2 more
openaire +2 more sources
Allogeneic Marrow Transplantation
Cancer Investigation, 1984After 15 years of clinical investigation, allogeneic marrow transplantation can be considered the treatment of choice for a variety of hematologic and immunologic diseases. This review has focused upon some of the principles, current results, problems, and future directions in allogeneic marrow grafting.
K M, Sullivan, R, Storb
openaire +2 more sources
SEROLOGIC ALLOGENEIC CHIMERISM
Transplantation, 1997At least some transplanted livers secrete soluble human leukocyte antigens (sHLA) of donor phenotype into the body fluids of recipients. The individuals in whom this phenomenon occurs are by definition serologic allogeneic chimeras. Because an allogeneic transplanted liver may induce tolerance to itself and other organs in animals of the donor strain ...
J C, McDonald +6 more
openaire +2 more sources
Allogeneic Pregnancy as Immunoabsorbent
The Journal of Immunology, 1977Abstract Experiments in the past have indicated that both human and rodent females undergo immune recognition of paternally derived antigens during pregnancy. Although the mechanisms that allow pregnancy to proceed in the face of this process have not yet been clarified, one simple possibility is that the paternal strain antigens are ...
Wegmann, T G, Carlson, G A
openaire +2 more sources
Allogeneic transplantation for haemoglobinopathies
Best Practice & Research Clinical Haematology, 2001Beta-thalassaemia major and sickle-cell disease (SCD) reduce lifespan and quality of life for >300000 children and young adults worldwide. The only cure for both disorders is allogeneic stem cell transplantation (SCT). The decision-making processes in recommending SCT for patients with thalassaemia and SCD are different.
G, Vassiliou, P, Amrolia, I A, Roberts
openaire +2 more sources
Allogeneic Transplantation for Lymphoma
Journal of Clinical Oncology, 2011Historically, high levels of treatment-related mortality restricted the use of standard myeloablative allogeneic stem-cell transplantation to a minority of young and fit patients with lymphoma. Over the last decade, increasing numbers of patients with lymphoma have undergone allogeneic stem-cell transplantation using reduced-intensity protocols that ...
Ronjon, Chakraverty, Stephen, Mackinnon
openaire +2 more sources
Allogeneic Platelet-Rich Plasma Therapy as an Effective and Safe Adjuvant Method for Chronic Wounds.
Journal of Surgical Research, 2020BACKGROUND Platelet-rich plasma (PRP) improves the healing of refractory wounds, and its application is receiving more attention in the field of wound repair. However, when a patient's condition is very poor, it may be difficult to provide whole blood to
Xuan Liao +7 more
semanticscholar +1 more source
2011
A segmental nerve defect is still best be treated by autologous nerve graft. However, besides its donor side morbidity, extensive nerve defects of peripheral nerves or the brachial plexus often cannot be completely treated due to missing quantity of autologous nerve graft material.
A, Berger, R, Hierner, G F, Walter
openaire +2 more sources
A segmental nerve defect is still best be treated by autologous nerve graft. However, besides its donor side morbidity, extensive nerve defects of peripheral nerves or the brachial plexus often cannot be completely treated due to missing quantity of autologous nerve graft material.
A, Berger, R, Hierner, G F, Walter
openaire +2 more sources
Allogeneic Stem Cell Transplantation
Transplantation Proceedings, 2005Allogeneic stem cell transplantation (HSCT) requires the harvest of an adequate number of stem cells (SC) from a histocompatible donor and their infusion into a patient following a conditioning regimen. During the past 35 years, the role of HSCT has changed from an experimental procedure for terminally ill patients to a curative treatment.
BOSI, ALBERTO, BARTOLOZZI B, GUIDI S.
openaire +3 more sources